Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system

Peptides

Volumn 21, Issue 7, 2000, Pages 1023-1029

  Schlicker, E ^a   Morari, M ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

5 HT); 5 Hydroxytryptamine (serotonin; Acetylcholine; Glutamate; Naloxone benzoylhydrazone; Nociceptin; Noradrenaline; Orphanin FQ; Nphe1 Nociceptin (1 13)NH2; Phe1 (CH2 NH)Gly2 Nociceptin(1 13)NH2

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DOPAMINE; GLUTAMIC ACID; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; NORADRENALIN; POTASSIUM ION; SEROTONIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ANTAGONISM; ELECTROSTIMULATION; GUINEA PIG; LOCOMOTION; MESENCEPHALON; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REVIEW; SEROTONIN RELEASE;

EID: 0033821477     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00233-3     Document Type: Article

References (60)

1. 3H]-noradrenaline from isolated human atrial appendages. Naunyn-Schmiedeberg's Arch Pharmacol. 355:1997;384-389.
2. Albin R.A., Young A.B., Penney B. The functional anatomy of the basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. 1) receptor. Naunyn-Schmiedeberg's Arch Pharmacol. 359:1999;17-20.
4. Bliss T.V.P., Collingridge G.L. A synaptic model of memory long-term potentiation in the hippocampus . Nature. 361:1993;31-39.
5. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem. 41:1998;3360-3366.
6. Calò G., Rizzi A., Marzola G., et al. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol. 125:1998;373-378.
7. 2, a new selective nociceptin receptor antagonist. Br J Pharmacol. 129:2000;1183-1193.
8. 3 subtype . J Pharmacol Exp Ther. 251:1989;461-468.
9. Devine DP, Taylor L, Reinscheid RK, Monsma FJ, Civelli O, Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. 1996;21:1387-96.
10. Dhawan B.N., Cesselin F., Raghubir R., et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. 48:1996;567-592.
11. Di Giannuario A., Pieretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens a microdialysis study in rats . Neurosci Lett. 272:1999;183-186.
12. Dooley C.T., Spaeth C.G., Berzetei-Gurske I.P., et al. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther. 283:1997;735-741.
13. Dunnill R.J., Kakizawa K., McKnight A.T., Henderson G. Characterization of the actions of naloxone benzoylhydrazone at μ-opioid, κ-opioid and ORL1 receptors in isolated tissues from rat and guinea-pig. Br J Pharmacol. 119:1996;275P.
14. Göthert M., Schlicker E. Regulation of 5-HT release in the CNS by presynaptic 5-HT autoreceptors and by 5-HT heteroreceptors. Baumgarten H.W., Göthert M. Serotoninergic neurons and 5-HT receptors in the CNS handbook of experimental pharmacology (Vol. 129) . 1997;307-350 Springer, Berlin.
15. Guerrini R., Calo G., Rizzi A., et al. A new selective antagonist of the nociceptin receptor. Br J Pharmacol. 123:1998;163-165.
16. Hamon M. The new approach to opioid receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 358:(suppl. 2):1998;R581.
17. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. 18:1997;293-300.
18. Kenakin T. Pharmacologic analysis of drug-receptor interaction (2nd ed.). 1997;Raven, New York.
19. Illes P. Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev Physiol Biochem Pharmacol. 112:1989;139-233.
20. Itoh K., Konya H., Takai E., Masuda H., Nagai K. Modification of acetylcholine release by nociceptin in conscious rat striatum. Brain Res. 845:1999;242-245.
21. Jackisch R. Regulation of neurotransmitter release by opiates and opioid peptides in the central nervous system. Feigenbaum J., Hanani M. Presynaptic regulation of neurotransmitter release a handbook . 1991;551-592 Freund Publishing House, Tel Aviv.
22. Kawamoto H., Ozaki S., Itoh Y., et al. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist 1-[(3R,4R)-1-cyclooctylmethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol- 2-one (J-113397) . J Med Chem. 42:1999;5061-5063.
23. Konya H., Masuda H., Itoh K., Nagai K., Kakishita E., Matsuoka A. Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res. 788:1998;341-344.
24. 1 in neuroblastoma × glioma NG 108-15 hybrid cells. FEBS Lett. 403:1997;91-94.
25. Maggi CA, et al. Nociceptin and neurotransmitter release in the periphery. Peptides, In press.
26. 1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 361:2000;80-84.
27. Mamyia T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Nociceptin system plays a role in the memory retention involvement of naloxone benzoylhydrazone binding sites . NeuroReport. 10:1999;1171-1175.
28. 3H]-5-HT release from rat cortical slices. Soc Neurosci Abstr. 25:1999;433.
29. Marti M., Sbrenna S., Calò G., et al. Facilitation of glutamate release via ORL1 receptors in the substantia nigra. A microdialysis study in the awake rat. Regul Pept. 80:1999;124.
30. Meunier J.C. Nociceptin/orphanin FQ, and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
31. 1 receptor. Nature. 377:1995;532-535.
32. Mogil JS, et al. Nociceptin effects on pain threshold at supraspinal level. Peptides, In press.
33. Montiel J.L., Cornille F., Roques B.P., Noble F. Nociceptin/orphanin FQ metabolism role of aminopeptidase and endopeptidase 24 . 15. J Neurochem. 68:1997;354-361.
34. 2+ channel inhibition and its desensitization in NG108-15 cells. Eur J Pharmacol. 351:1998;247-252.
35. Mulder A.H., Schoffelmeer A.N.M. Multiple opioid receptors and presynaptic modulation of neurotransmitter relase in the brain. Herz A., Akil H., Simon E.J. Opioids I. Handbook of experimental pharmacology (Vol. 104/I). 1993;125-144 Springer, Berlin.
36. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience. 75:1996;1-4.
37. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem. 73:1999;179-186.
38. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
39. Murphy NP, Tan AM, Lam HA, Maidment NT. Orphanin FQ/nociceptin modulation of dopamine release from midbrain primary cultures. 30th International Narcotics Research Conference. 1999;Abstract Sun72. Web site, http://osu.com.okstate.edu/inrc/index.htm.
40. Nicholson J.R., Paterson S.J., Menzies J.R.W., Corbett A.D., McKnight A.T. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites. Can J Physiol Pharmacol. 76:1998;304-313.
41. +-evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol. 119:1996;1081-1083.
42. Nicol B., Lambert D.G., Rowbotham D.J., et al. Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices. Eur J Pharmacol. 356:1998;R1-R3.
43. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higasioka M., Takeshima H. Loss of antinociceptin induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J Biol Chem. 273:1998;18047-18051.
44. 2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol. 127:1999;123-130.
45. Okuda-Ashitaka E., Minami T., Tachibana S., et al. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
46. Sandin J., Georgieva J., Schött P.A., Ögren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
47. Sbrenna S., Marti M., Morari M., et al. L-Glutamate, and γ-aminobutyric acid efflux from rat cerebrocortical synaptosomes modulation by κ- and μ-, but not δ- and opioid receptor like-receptors . J Pharmacol Exp Ther. 291:1999;1365-1371.
48. 2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull. 47:1998;129-132.
49. Schlicker E., Werthwein S., Kathmann M. Orphan opioid receptor-mediated inhibition of noradrenaline, dopamine and serotonin release in the mouse, rat and guinea-pig brain. Naunyn-Schmiedeberg's Arch Pharmacol. 357:(Suppl.):1998;R90.
50. 1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 358:1998;418-422.
51. 3H]-5-HT release from rat cerebral cortex slices. Br J Pharmacol. 128:1999;119-123.
52. Siniscalchi A., Rodi S., Sbrenna S., Marti M., Bianchi C. Species difference in nociceptin inhibition of cortical noradrenaline release in vitro. Regul Pept. 80:1999;127.
53. Smith PA. Electrophysiological actions of nociceptin. Peptides, In press.
54. 3H]U69593. J Neurochem. 53:1989;27-36.
55. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 69:1989;864-989.
56. 1] nociceptin analogs receptor binding and bioassay studies . Naunyn-Schmiedeberg's Arch Pharmacol. 360:1999;270-277.
57. 1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br J Pharmacol. 127:1999;300-308.
58. Wiesenfeld-Hallin Z., et al. Nociceptin effects on pain threshold at spinal level. Peptides, In press.
59. Yu T.P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
60. Zgodzinski W, Rubaj A, Gustaw K, Sieklucka-Dzuiba M, Kleinrok Z. Anticonvulsant effects of orphanin/FQ receptors ligands. 30th International Narcotics Research Conference. 1999;Abstract Sun70. Web site, http://osu.com.okstate.edu/inrc/index.htm.